Oragenics, Inc. (NYSE:OGEN) recovered 155.26% of its value since hitting low of $0.38. The recent move of -1.52% drop pushed the stock to close at $0.97 when trading ended on 01/17/2019. At recent session, the prices were hovering between $0.95 and $1.02. This company shares are 106.19% off its target price of $2 and the current market capitalization stands at $29.97M. The recent change has given its price a 1.63% lead over SMA 50 and -76.9% deficit over its 52-week high. The stock witnessed 14.12% gains, -14.91% declines and 46.73% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found OGEN’s volatility during a week at 11.11% and during a month it has been found around 9.97%.Oragenics, Inc. (OGEN) Top Holders
Institutional investors currently hold around $3 million or 13.2% in OGEN stock. Look at its top three institutional owners. Third Security, Llc owns $1.53 million in Oragenics, Inc., which represents roughly 5.09% of the company’s market cap and approximately 50.83% of the institutional ownership. Similar statistics are true for the second largest owner, Wexford Capital Lp, which owns 600,000 shares of the stock are valued at $591 thousand. The third largest holder is Fmr Llc, which currently holds $153 thousand worth of this stock and that ownership represents nearly 0.51% of its market capitalization.Oragenics, Inc. 13F Filings
At the end of September reporting period, 6 institutional holders increased their position in Oragenics, Inc. (NYSE:OGEN) by some 838,715 shares, 5 decreased positions by 95,037 and 6 held positions by 1,761,987. That puts total institutional holdings at 2,695,739 shares, according to SEC filings. The stock grabbed 4 new institutional investments totaling 680,245 shares while 4 institutional investors sold out their entire positions totaling 84,176 shares.Oragenics, Inc. (NYSE:OGEN) Insider Trades
Multiple company employees have indulged in significant insider trading. Oragenics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Koski Family Lp has acquired 169,050 shares of Oragenics, Inc. (OGEN) in trading session dated Sep. 18, 2018. These shares are worth $71,001 and were traded at $0.42 each. The SEC filing shows that Kirk Randal J performed a purchase of 226,142 shares. The 10% Owner added these shares by way of transaction on Jun. 30, 2016. The company’s shares were assimilated at $5.2 per share worth to an investment of some $1,175,938 on account of Kirk Randal J.
10% Owner, Koski Family Lp, purchased 5,815,080 common shares of Oragenics, Inc. (OGEN) in the open market. In a transaction dated Jun. 30, 2016, the shares were bought at an average price of $0.52, giving away a sum of $3,023,842. After this purchase, 1,478,517 common shares of OGEN are directly owned by the insider, with total stake valued at $1,434,162.
In the transaction dated Jun. 30, 2016, the great number of shares acquired came courtesy the Director; Telling Fred added a total of 969,180 shares at an average price of $0.52, amounting to approximately $503,974. The insider now directly owns 1,315,354 shares worth $1,275,893.